2006/140/EC: Commission Decision of  15 February 2006  concerning a specific financial contribution by the Community relating to the survey on TSE resistant PrP genes in goats presented by Cyprus for the year 2006  (notified under document number C(2006) 408)
Date: 2006-02-15
Institutions: European Commission
Subjects: Cyprus, EU financing, bovine spongiform encephalopathy, financial aid, goat, medical research, veterinary medicine

L 54/44

EN

Official Journal of the European Union

24.2.2006

COMMISSION DECISION

of 15 February 2006

concerning a specific financial contribution by the Community relating to the survey on TSE
resistant PrP genes in goats presented by Cyprus for the year 2006

(notified under document number C(2006) 408)

(Only the Greek text is authentic)

(2006/140/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Decision 90/424/EEC of 26 June
1990 on expenditure in the veterinary field (1), and in particular
Article 20 thereof,

Whereas:

(1)

(2)

(3)

(4)

Eradication of transmissible spongiform encephalopathies
(TSEs) in small ruminants, including bovine spongiform
encephalopathy (BSE) which is considered to be the cause
of the fatal variant Creutzfeld Jacob disease in humans, is
of major importance for animal health and consumer’s
protection.

tool

is a major

In sheep, selection towards resistant prion protein (PrP)
genes
to achieve TSE eradication.
Therefore minimum requirements for the establishment
of breeding programmes for resistance to TSEs in sheep
have
in Commission Decision
2003/100/EC (2). Very limited information is however
available on TSE resistant PrP genes in goats.

down

been

laid

Verification of the existence of TSE resistant genotypes in
goats is necessary in order to develop community legis-
lation in the veterinary field, in particular on the control
and possible eradication of TSEs in such animals.

A bi-annual survey on TSEs resistant genotypes in goats
was submitted by the Cypriot authorities in 2005, with a
view to obtain financial support from the Community.
The objectives of the survey are to further investigate the
PrP gene of the Cyprus goats in order to confirm the

(1) OJ L 224, 18.8.1990, p. 19. Decision as last amended by Directive
2003/99/EC of the European Parliament and of the Council (OJ L
325, 12.12.2003, p. 31).
(2) OJ L 41, 14.2.2003, p. 41.

results of previous preliminary studies where specific PrP
polymorphisms were found indicating resistance against
TSEs and to evaluate the data in order to be able to
determine the baseline prevalence of TSE resistant PrP
genes in goats. Cyprus has a very high prevalence of
TSEs in goats and is therefore the appropriate Member
State to carry out such pilot project. The survey intends
to start on 1 January 2006.

The survey will be executed by the Veterinary Services of
the Ministry of Agriculture, Natural Resources and Envir-
onment
Reference
The
Laboratory for TSE will provide scientific supervision of
the survey.

Community

Cyprus.

of

Pursuant to Article 3, paragraph 2, of Council Regulation
(EC) No 1258/1999 (3), veterinary and plant health
measures undertaken in accordance with Community
rules shall be financed under the Guarantee Section of
the European Agricultural Guidance and Guarantee Fund;
for financial control purposes, Articles 8 and 9 of Regu-
lation (EC) No 1258/1999 apply.

A financial contribution from the Community shall be
granted in so far as the actions provided for are effec-
tively carried out and provided that
the authorities
furnish all
the necessary information within the time
limits provided for. For budgetary reasons, Community
assistance is decided each year.

There is a need to clarify the rate to be used for the
conversion of
the payment applications submitted in
national currency as defined in Article 1(d) of Council
Regulation (EC) No 2799/98 of 15 December 1998
establishing agrimonetary arrangements for the euro (4).

The measures provided for
accordance with
Committee on the Food Chain and Animal Health,

in this Decision are in
Standing
the

opinion

the

of

(5)

(6)

(7)

(8)

(9)

(3) OJ L 160, 26.6.1999, p. 103.
(4) OJ L 349, 24.12.1998, p. 1.

24.2.2006

EN

Official Journal of the European Union

L 54/45

HAS ADOPTED THIS DECISION:

Article 1

evaluation covering the year 2006, in accordance with the
model as set out in Chapter 2 of the Annex, accompanied
by justifying evidence as to the costs incurred;

The survey programme for TSE resistant PrP genes in
1.
goats presented by Cyprus is hereby approved for a period of
12 months starting from 1 January 2006.

(d) these reports providing substantive and valuable technical
and scientific information corresponding to the purpose of
the Community intervention;

The financial assistance from the Community for the
2.
programme referred to in paragraph 1 covers the costs (VAT
excluded) incurred by Cyprus for laboratory testing up to 100 %
in accordance with the provisions in Chapter 1 of the Annex.
The total assistance shall be maximum EUR 47 500.

(e) implementing the programme effectively.

2. When the time limit in subparagraph 1(c) is not respected,
the contribution shall be reduced by 25 % on 1 May, 50 % on
1 June, 75 % on 1 July and 100 % on 1 September 2007.

Article 2

Article 3

1.
The financial assistance referred to under Article 1(2) shall
be paid to Cyprus provided that the implementation of the
programme shall be in conformity with the relevant provisions
of Community law, including rules on competition and on the
award of public contracts and subject
to the conditions
provided for in points (a) to (e):

The conversion rate for payments of reimbursement claims
submitted in national currency in month ‘n’ shall be that of
the 10th day of month ‘n+1’ or for the first preceding day for
which a rate is quoted.

Article 4

(a) bringing into force by 1 January 2006 the laws, regulations
and administrative provisions for implementing the survey;

This Decision shall apply from 1 January 2006.

(b) forwarding

an

intermediate

technical
evaluation covering the first eight months of the survey,
at the latest two months after the end of this period. The
report shall conform to the model as set out in Chapter 2 of
the Annex;

financial

and

Article 5

This decision is addressed to the Republic of Cyprus.

Done at Brussels, 15 February 2006.

(c) forwarding a final report by 31 March 2007 at the latest on
the overall execution and results of the survey for the whole
period during which Community financial assistance was
granted. The report shall contain a technical and financial

For the Commission

Markos KYPRIANOU
Member of the Commission

L 54/46

EN

Official Journal of the European Union

24.2.2006

ANNEX

CHAPTER 1

Financial assistance of the Community

Costs

Number of units

Sample collection

Histological examination

PrP genotyping
DNA sequencing

70 hours

1 500 analyses

750 analyses

Unitary
cost in
EUR

21

3,5

60

1 470

5 250

45 000

Rapid testing

Test kits and
consumables

250 tests

14

3 500

Total cost in EUR

Community assistence

None

None

Costs of maximum 750
analyses at maximum
EUR 60 per analysis

Costs of maximum
250 tests at maximum
EUR 10 per test

Work

60 hours

Coordination and evaluation of data

1 778 hours

Traveling and accomodation costs CRL
expert

1 trip

20

14,5

1 300

1 200

25 780

1 300

None

None

None

Total

Maximum EUR 47 500

CHAPTER 2

Technical and financial reporting

Section A: Technical report

Reporting period from .........................................................................................to .........................................................................................

Determination of PrP genotype by DNA sequencing

Number of samples with at codon 146 amino acid:

Aspartic acid

Serine

…

Other

Histologically TSE + suspects, rapid test +
Histologically TSE + suspects, rapid test –
Histologically TSE – suspects, rapid test +
Histologically TSE – suspects, rapid test –

Healthy controls

Section B: Statement on costs incurred for control (1)

Reporting period from .........................................................................................to .........................................................................................

Reference number of Commission Decision providing financial assistance:

.....................................................................................

Costs incurred related to

Number of
units

Costs incurred during the reporting period
(national currency)

PrP genotyping by DNA sequencing. Number of tests:

Rapid testing. Number of tests:

Rapid testing. Hours of work:

(1) When presenting the final report referred to in Article 2(c), for each item a listing of all expenditures shall be provided together with a

copy of supporting documents.